Syon Capital’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.01M Buy
35,354
+1,784
+5% +$47.4K 0.04% 526
2026
Q2
$808K Sell
33,570
-134
-0.4% -$3.5K 0.04% 428
2026
Q1
$946K Sell
33,704
-1,326
-4% -$35.3K 0.05% 324
2025
Q4
$872K Sell
35,030
-4,097
-10% -$103K 0.04% 348
2025
Q3
$997K Buy
39,127
+3,898
+11% +$96.2K 0.05% 256
2025
Q2
$854K Sell
35,229
-15,738
-31% -$367K 0.06% 244
2025
Q1
$1.29M Buy
50,967
+2,348
+5% +$61.4K 0.11% 142
2024
Q4
$1.29M Buy
48,619
+973
+2% +$26.4K 0.12% 129
2024
Q3
$1.38M Sell
47,646
-4,979
-9% -$145K 0.12% 128
2024
Q2
$1.47M Buy
52,625
+772
+1% +$21.3K 0.14% 112
2024
Q1
$1.44M Sell
51,853
-12,591
-20% -$349K 0.14% 113
2023
Q4
$1.86M Buy
64,444
+33,961
+111% +$1.03M 0.19% 84
2023
Q3
$1.01M Buy
+30,483
New +$1.08M 0.13% 104

Other funds holding PFE

Syon Capital's PFE Position: Q3 2026 in Review

Syon Capital increased its Pfizer (PFE) stake by 5.3% in Q3 2026, buying an estimated $47.4K and bringing the position to 35,354 shares worth $1.01M. The position accounts for 0.04% of the portfolio, ranked #526.

Syon Capital first reported a position in PFE in Q3 2023 and has held it in 13 quarters since. The position peaked at $1.86M in Q4 2023. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Syon Capital held 35,354 shares of Pfizer worth $1.01M as of Q3 2026.
  • Syon Capital bought 1,784 Pfizer shares in Q3 2026, an estimated $47.4K.
  • Pfizer made up 0.04% of Syon Capital's portfolio in Q3 2026, its #526 holding.
  • Syon Capital first reported a position in Pfizer in Q3 2023 and has held it in 13 quarters since.
  • Syon Capital's Pfizer position peaked at $1.86M in Q4 2023.
  • 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Syon Capital's 13F filing for Q3 2026, filed 16 Nov 2026.